questionsmedicales.fr
Facteurs biologiques
Protéines et peptides de signalisation intercellulaire
Cytokines
Chimiokines
Chimiokines CC
Protéines chimioattractives monocytaires
Chimiokine CCL2
Chimiokine CCL2 : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Chimiokines
CCL2
Tests de laboratoire
Inflammation
CCL2
Protéines C-réactives
Biomarqueurs
Maladies auto-immunes
CCL2
Maladies cardiovasculaires
Inflammation
CCL2
Liquide céphalorachidien
Inflammation
CCL2
Symptômes
5
Symptômes
Inflammation
CCL2
Sclérose en plaques
Symptômes neurologiques
CCL2
Système immunitaire
Monocytes
CCL2
Douleur
Inflammation
CCL2
Prévention
5
Mode de vie sain
CCL2
Prévention
Alimentation
Antioxydants
CCL2
Sommeil
Inflammation
CCL2
Traitements
5
Inhibiteurs
Maladies inflammatoires
CCL2
Thérapies anticancéreuses
CCL2
Inflammation
Anti-inflammatoires
CCL2
Inflammation
Plantes médicinales
CCL2
Traitements naturels
Corticostéroïdes
CCL2
Inflammation
Complications
5
Complications
Maladies cardiovasculaires
CCL2
Maladies neurodégénératives
Alzheimer
CCL2
Diabète
Inflammation
CCL2
Infections
Inflammation
CCL2
Troubles auto-immuns
Polyarthrite
CCL2
Facteurs de risque
5
Infections chroniques
CCL2
Inflammation
Régime alimentaire
Graisses saturées
CCL2
Manque d'exercice
Inflammation
CCL2
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Chimiokine CCL2 : Questions médicales les plus fréquentes",
"headline": "Chimiokine CCL2 : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Chimiokine CCL2 : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-26",
"dateModified": "2025-02-20",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Chimiokine CCL2"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Protéines chimioattractives monocytaires",
"url": "https://questionsmedicales.fr/mesh/D018945",
"about": {
"@type": "MedicalCondition",
"name": "Protéines chimioattractives monocytaires",
"code": {
"@type": "MedicalCode",
"code": "D018945",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.529.374.200.110.990"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Chimiokine CCL2",
"alternateName": "Chemokine CCL2",
"code": {
"@type": "MedicalCode",
"code": "D018932",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Nidhi Joshi",
"url": "https://questionsmedicales.fr/author/Nidhi%20Joshi",
"affiliation": {
"@type": "Organization",
"name": "Department of Biotechnology, Indian Institute of Technology Roorkee, Roorkee 247667, Uttarakhand, India."
}
},
{
"@type": "Person",
"name": "Krishna Mohan Poluri",
"url": "https://questionsmedicales.fr/author/Krishna%20Mohan%20Poluri",
"affiliation": {
"@type": "Organization",
"name": "Department of Biotechnology, Indian Institute of Technology Roorkee, Roorkee 247667, Uttarakhand, India. Electronic address: krishfbt@iitr.ac.in."
}
},
{
"@type": "Person",
"name": "Nupur Nagar",
"url": "https://questionsmedicales.fr/author/Nupur%20Nagar",
"affiliation": {
"@type": "Organization",
"name": "Department of Biotechnology, Indian Institute of Technology Roorkee, Roorkee 247667, Uttarakhand, India."
}
},
{
"@type": "Person",
"name": "Élora Midavaine",
"url": "https://questionsmedicales.fr/author/%C3%89lora%20Midavaine",
"affiliation": {
"@type": "Organization",
"name": "Department of Pharmacology and Physiology, Faculty of Medicine and Health Sciences, Institut de pharmacologie de Sherbrooke, Université de Sherbrooke, 3001, 12e Avenue Nord, Sherbrooke, QC, Canada. elora.midavaine@usherbrooke.ca."
}
},
{
"@type": "Person",
"name": "Philippe Sarret",
"url": "https://questionsmedicales.fr/author/Philippe%20Sarret",
"affiliation": {
"@type": "Organization",
"name": "Department of Pharmacology and Physiology, Faculty of Medicine and Health Sciences, Institut de pharmacologie de Sherbrooke, Université de Sherbrooke, 3001, 12e Avenue Nord, Sherbrooke, QC, Canada."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Challenges of Applying Automated Polysomnography Scoring at Scale.",
"datePublished": "2023-06-15",
"url": "https://questionsmedicales.fr/article/37532369",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jsmc.2023.05.002"
}
},
{
"@type": "ScholarlyArticle",
"name": "Impact of sleep chronotype on in-laboratory polysomnography parameters.",
"datePublished": "2023-05-07",
"url": "https://questionsmedicales.fr/article/37150591",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/jsr.13922"
}
},
{
"@type": "ScholarlyArticle",
"name": "Evaluation of polysomnography findings in children with genetic skeletal disorders.",
"datePublished": "2023-05-01",
"url": "https://questionsmedicales.fr/article/37128177",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/jsr.13914"
}
},
{
"@type": "ScholarlyArticle",
"name": "The importance and limitations of polysomnography in insomnia disorder-a critical appraisal.",
"datePublished": "2023-09-07",
"url": "https://questionsmedicales.fr/article/37680011",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/jsr.14036"
}
},
{
"@type": "ScholarlyArticle",
"name": "Sleep disorders and polysomnography findings in patients with autoimmune encephalitis.",
"datePublished": "2022-12-01",
"url": "https://questionsmedicales.fr/article/36454441",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10072-022-06513-x"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Facteurs biologiques",
"item": "https://questionsmedicales.fr/mesh/D001685"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines et peptides de signalisation intercellulaire",
"item": "https://questionsmedicales.fr/mesh/D036341"
},
{
"@type": "ListItem",
"position": 4,
"name": "Cytokines",
"item": "https://questionsmedicales.fr/mesh/D016207"
},
{
"@type": "ListItem",
"position": 5,
"name": "Chimiokines",
"item": "https://questionsmedicales.fr/mesh/D018925"
},
{
"@type": "ListItem",
"position": 6,
"name": "Chimiokines CC",
"item": "https://questionsmedicales.fr/mesh/D019742"
},
{
"@type": "ListItem",
"position": 7,
"name": "Protéines chimioattractives monocytaires",
"item": "https://questionsmedicales.fr/mesh/D018945"
},
{
"@type": "ListItem",
"position": 8,
"name": "Chimiokine CCL2",
"item": "https://questionsmedicales.fr/mesh/D018932"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Chimiokine CCL2 - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Chimiokine CCL2",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-13",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Chimiokine CCL2",
"description": "Comment mesurer les niveaux de CCL2 ?\nQuels tests sont utilisés pour évaluer l'inflammation ?\nCCL2 est-il un biomarqueur de maladies ?\nComment CCL2 est-il lié à la maladie cardiovasculaire ?\nPeut-on détecter CCL2 dans le liquide céphalorachidien ?",
"url": "https://questionsmedicales.fr/mesh/D018932?mesh_terms=Polysomnography#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Chimiokine CCL2",
"description": "Quels symptômes sont associés à des niveaux élevés de CCL2 ?\nCCL2 est-il lié à des symptômes neurologiques ?\nComment CCL2 affecte-t-il le système immunitaire ?\nDes niveaux de CCL2 peuvent-ils causer de la douleur ?\nCCL2 est-il impliqué dans des maladies respiratoires ?",
"url": "https://questionsmedicales.fr/mesh/D018932?mesh_terms=Polysomnography#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Chimiokine CCL2",
"description": "Comment réduire les niveaux de CCL2 ?\nLe stress influence-t-il CCL2 ?\nY a-t-il des aliments qui réduisent CCL2 ?\nL'exercice physique affecte-t-il CCL2 ?\nLa qualité du sommeil influence-t-elle CCL2 ?",
"url": "https://questionsmedicales.fr/mesh/D018932?mesh_terms=Polysomnography#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Chimiokine CCL2",
"description": "Quels traitements ciblent CCL2 ?\nCCL2 peut-il être une cible pour des thérapies anticancéreuses ?\nComment les anti-inflammatoires affectent-ils CCL2 ?\nY a-t-il des traitements naturels pour CCL2 ?\nLes corticostéroïdes influencent-ils CCL2 ?",
"url": "https://questionsmedicales.fr/mesh/D018932?mesh_terms=Polysomnography#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Chimiokine CCL2",
"description": "Quelles complications sont liées à CCL2 ?\nCCL2 est-il impliqué dans des maladies neurodégénératives ?\nComment CCL2 affecte-t-il le diabète ?\nY a-t-il des risques d'infection liés à CCL2 ?\nCCL2 est-il lié à des troubles auto-immuns ?",
"url": "https://questionsmedicales.fr/mesh/D018932?mesh_terms=Polysomnography#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Chimiokine CCL2",
"description": "Quels facteurs augmentent CCL2 ?\nL'âge influence-t-il les niveaux de CCL2 ?\nLes infections chroniques affectent-elles CCL2 ?\nLe régime alimentaire influence-t-il CCL2 ?\nLe manque d'exercice est-il un facteur de risque pour CCL2 ?",
"url": "https://questionsmedicales.fr/mesh/D018932?mesh_terms=Polysomnography#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment mesurer les niveaux de CCL2 ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les niveaux de CCL2 peuvent être mesurés par des tests ELISA dans le sérum ou les tissus."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer l'inflammation ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests comme la CRP et la mesure de CCL2 aident à évaluer l'inflammation."
}
},
{
"@type": "Question",
"name": "CCL2 est-il un biomarqueur de maladies ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, CCL2 est un biomarqueur potentiel pour des maladies inflammatoires et auto-immunes."
}
},
{
"@type": "Question",
"name": "Comment CCL2 est-il lié à la maladie cardiovasculaire ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des niveaux élevés de CCL2 sont associés à l'inflammation dans les maladies cardiovasculaires."
}
},
{
"@type": "Question",
"name": "Peut-on détecter CCL2 dans le liquide céphalorachidien ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, CCL2 peut être détecté dans le liquide céphalorachidien, indiquant une inflammation neurologique."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont associés à des niveaux élevés de CCL2 ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des niveaux élevés de CCL2 peuvent entraîner des symptômes d'inflammation comme douleur et fatigue."
}
},
{
"@type": "Question",
"name": "CCL2 est-il lié à des symptômes neurologiques ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, CCL2 est impliqué dans des symptômes neurologiques dans des maladies comme la sclérose en plaques."
}
},
{
"@type": "Question",
"name": "Comment CCL2 affecte-t-il le système immunitaire ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "CCL2 attire les monocytes et les lymphocytes, influençant la réponse immunitaire."
}
},
{
"@type": "Question",
"name": "Des niveaux de CCL2 peuvent-ils causer de la douleur ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, CCL2 peut contribuer à la douleur en favorisant l'inflammation dans les tissus."
}
},
{
"@type": "Question",
"name": "CCL2 est-il impliqué dans des maladies respiratoires ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, CCL2 est associé à des maladies respiratoires comme l'asthme et la BPCO."
}
},
{
"@type": "Question",
"name": "Comment réduire les niveaux de CCL2 ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Adopter un mode de vie sain, avec une alimentation équilibrée et de l'exercice, peut aider."
}
},
{
"@type": "Question",
"name": "Le stress influence-t-il CCL2 ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut augmenter les niveaux de CCL2 et l'inflammation."
}
},
{
"@type": "Question",
"name": "Y a-t-il des aliments qui réduisent CCL2 ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des aliments riches en antioxydants, comme les baies, peuvent aider à réduire CCL2."
}
},
{
"@type": "Question",
"name": "L'exercice physique affecte-t-il CCL2 ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier peut diminuer les niveaux de CCL2 et améliorer la santé globale."
}
},
{
"@type": "Question",
"name": "La qualité du sommeil influence-t-elle CCL2 ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un sommeil de qualité peut réduire l'inflammation et les niveaux de CCL2 dans le corps."
}
},
{
"@type": "Question",
"name": "Quels traitements ciblent CCL2 ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des inhibiteurs de CCL2 sont en développement pour traiter des maladies inflammatoires."
}
},
{
"@type": "Question",
"name": "CCL2 peut-il être une cible pour des thérapies anticancéreuses ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, cibler CCL2 pourrait aider à réduire l'infiltration tumorale et l'inflammation."
}
},
{
"@type": "Question",
"name": "Comment les anti-inflammatoires affectent-ils CCL2 ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les anti-inflammatoires peuvent réduire les niveaux de CCL2 et atténuer l'inflammation."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements naturels pour CCL2 ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines plantes médicinales peuvent moduler les niveaux de CCL2, mais des études sont nécessaires."
}
},
{
"@type": "Question",
"name": "Les corticostéroïdes influencent-ils CCL2 ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les corticostéroïdes peuvent réduire l'expression de CCL2 dans les tissus inflammés."
}
},
{
"@type": "Question",
"name": "Quelles complications sont liées à CCL2 ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des niveaux élevés de CCL2 peuvent entraîner des complications dans les maladies cardiovasculaires."
}
},
{
"@type": "Question",
"name": "CCL2 est-il impliqué dans des maladies neurodégénératives ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, CCL2 est associé à des complications dans des maladies comme Alzheimer et Parkinson."
}
},
{
"@type": "Question",
"name": "Comment CCL2 affecte-t-il le diabète ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "CCL2 peut contribuer à l'inflammation et aux complications associées au diabète."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques d'infection liés à CCL2 ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des niveaux élevés de CCL2 peuvent augmenter le risque d'infections en favorisant l'inflammation."
}
},
{
"@type": "Question",
"name": "CCL2 est-il lié à des troubles auto-immuns ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, CCL2 est impliqué dans des complications de troubles auto-immuns comme la polyarthrite."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent CCL2 ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le tabagisme, l'obésité et le stress sont des facteurs de risque augmentant CCL2."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il les niveaux de CCL2 ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les niveaux de CCL2 tendent à augmenter avec l'âge, contribuant à l'inflammation."
}
},
{
"@type": "Question",
"name": "Les infections chroniques affectent-elles CCL2 ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les infections chroniques peuvent augmenter les niveaux de CCL2 dans le corps."
}
},
{
"@type": "Question",
"name": "Le régime alimentaire influence-t-il CCL2 ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un régime riche en graisses saturées peut augmenter les niveaux de CCL2 et l'inflammation."
}
},
{
"@type": "Question",
"name": "Le manque d'exercice est-il un facteur de risque pour CCL2 ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le manque d'exercice peut contribuer à des niveaux élevés de CCL2 et à l'inflammation."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 20/02/2025
Contenu vérifié selon les dernières recommandations médicales
4 publications dans cette catégorie
Affiliations :
Department of Biotechnology, Indian Institute of Technology Roorkee, Roorkee 247667, Uttarakhand, India.
Publications dans "Chimiokine CCL2" :
4 publications dans cette catégorie
Affiliations :
Department of Biotechnology, Indian Institute of Technology Roorkee, Roorkee 247667, Uttarakhand, India. Electronic address: krishfbt@iitr.ac.in.
Publications dans "Chimiokine CCL2" :
3 publications dans cette catégorie
Affiliations :
Department of Biotechnology, Indian Institute of Technology Roorkee, Roorkee 247667, Uttarakhand, India.
Publications dans "Chimiokine CCL2" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmacology and Physiology, Faculty of Medicine and Health Sciences, Institut de pharmacologie de Sherbrooke, Université de Sherbrooke, 3001, 12e Avenue Nord, Sherbrooke, QC, Canada. elora.midavaine@usherbrooke.ca.
Centre de recherche du Centre hospitalier universitaire de Sherbrooke, CIUSSS de l'Estrie - CHUS, Sherbrooke, QC, Canada. elora.midavaine@usherbrooke.ca.
Publications dans "Chimiokine CCL2" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmacology and Physiology, Faculty of Medicine and Health Sciences, Institut de pharmacologie de Sherbrooke, Université de Sherbrooke, 3001, 12e Avenue Nord, Sherbrooke, QC, Canada.
Centre de recherche du Centre hospitalier universitaire de Sherbrooke, CIUSSS de l'Estrie - CHUS, Sherbrooke, QC, Canada.
Publications dans "Chimiokine CCL2" :
2 publications dans cette catégorie
Affiliations :
Centre of Biomedical Research, SGPGIMS Campus, Lucknow 226014, Uttar Pradesh, India.
Publications dans "Chimiokine CCL2" :
2 publications dans cette catégorie
Affiliations :
Department of Biosciences and Bioengineering, Indian Institute of Technology Roorkee, Roorkee 247667, Uttarakhand, India.
Publications dans "Chimiokine CCL2" :
2 publications dans cette catégorie
Affiliations :
Institute of Pharmaceutical Sciences, University of Graz, 8010 Graz, Austria.
Publications dans "Chimiokine CCL2" :
2 publications dans cette catégorie
Affiliations :
Institute of Pharmaceutical Sciences, University of Graz, 8010 Graz, Austria.
Publications dans "Chimiokine CCL2" :
2 publications dans cette catégorie
Affiliations :
Department of Rehabilitation Medicine, Affiliated Hospital of Nantong University, 226001, Nantong, Jiangsu Province, China.
School of Medicine, Nantong University, 226001, Nantong, Jiangsu Province, China.
Publications dans "Chimiokine CCL2" :
2 publications dans cette catégorie
Affiliations :
Istituti Clinici Scientifici Maugeri IRCCS, Unit of Internal Medicine and Endocrinology, Laboratory for Endocrine Disruptors, Pavia, Italy.
Publications dans "Chimiokine CCL2" :
2 publications dans cette catégorie
Affiliations :
Istituti Clinici Scientifici Maugeri IRCCS, Unit of Internal Medicine and Endocrinology, Laboratory for Endocrine Disruptors, Pavia, Italy.
Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy.
Publications dans "Chimiokine CCL2" :
2 publications dans cette catégorie
Affiliations :
Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56126 Pisa, Italy.
Publications dans "Chimiokine CCL2" :
2 publications dans cette catégorie
Affiliations :
Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy.
Publications dans "Chimiokine CCL2" :
2 publications dans cette catégorie
Affiliations :
Department of Surgical, Medical and Molecular Pathology and Critical Area, University of Pisa, 56126 Pisa, Italy.
Publications dans "Chimiokine CCL2" :
2 publications dans cette catégorie
Affiliations :
Department of Transplantation Medicine, Nephrology and Internal Medicine, Medical University of Warsaw, Warsaw, Poland. jgozdowska@wum.edu.pl
Publications dans "Chimiokine CCL2" :
2 publications dans cette catégorie
Affiliations :
Department of General and Transplantation Surgery, Medical University of Warsaw, Warsaw, Poland
Publications dans "Chimiokine CCL2" :
2 publications dans cette catégorie
Affiliations :
Department of Transplantation Medicine, Nephrology and Internal Medicine, Medical University of Warsaw, Warsaw, Poland
Publications dans "Chimiokine CCL2" :
2 publications dans cette catégorie
Affiliations :
College of Medicine and Sharjah Institute for Medical Research, University of Sharjah, Sharjah, United Arab Emirates.
Publications dans "Chimiokine CCL2" :
2 publications dans cette catégorie
Affiliations :
College of Medicine and Sharjah Institute for Medical Research, University of Sharjah, Sharjah, United Arab Emirates.
Publications dans "Chimiokine CCL2" :
Automatic polysomnography analysis can be leveraged to shorten scoring times, reduce associated costs, and ultimately improve the overall diagnosis of sleep disorders. Multiple and diverse strategies ...
Morningness-eveningness preference, also known as chronotype, is the tendency for a person to sleep during certain hours of the day and is broadly categorised into morning and evening types. In-labora...
Children with genetic skeletal disorders have variable conditions that can lead to sleep-disordered breathing, and polysomnography is the gold standard for diagnosing this condition. We aimed to revie...
The importance polysomnography (PSG) in the diagnosis and treatment process of insomnia disorder (ID) remains highly disputed. This review summarises the state of the science regarding PSG indications...
Sleep disorders in patients with autoimmune encephalitis (AE) are increasingly reported. Early recognition and treatment have significant importance regarding the potential of sleep disorders' effect ...
Seventeen patients with diagnosed AE and acute or subacute onset sleep complaints who underwent video-electroencephalography-PSG recordings in our tertiary center were investigated....
The mean age was 50, with eight females and nine males. The detected antibodies were against leucine-rich glioma-inactivated 1(LGI-1) in 6, anti-contactin-associated protein-2(CASPR2) in 3, voltage-ga...
Sleep disorders are frequent and essential components of AEs. Systematic clinical questionnaires and routine PSG assessments would significantly impact the correct diagnosis and proper treatment of SR...
To characterize 1) the relationship between laxative use and objective sleep metrics, and 2) the relationship between laxative use and self-reported insomnia symptoms in a convenience sample of middle...
We cross-sectionally analyzed first-night diagnostic in-laboratory polysomnography data for 2946 patients over the age of 40 (mean age 60.5 years; 48.3% male). Laxative use and medical comorbidities w...
After adjusting for age, sex, body mass index, total recording time, and relevant comorbidities, laxative users had a 7.1% lower sleep efficiency (...
Laxative use is associated with impairments in objective sleep continuity. Patients using laxatives were also at greater odds of reporting insomnia symptoms....
We provide an umbrella review of the reported polysomnographic changes in patients with neuropsychiatric diseases compared with healthy controls....
An electronic literature search was conducted in EMBASE, MEDLINE, All EBM databases, CINAHL, and PsycINFO. Meta-analyses of case-control studies investigating the polysomnographic changes in patients ...
We identified 27 articles, including 465 case-control studies in 27 neuropsychiatric diseases. The levels of evidence of polysomnographic changes in neuropsychiatric diseases were highly suggestive fo...
The credibility of evidence for sleep characteristics in 27 neuropsychiatric diseases varied across polysomnographic variables and diseases. When considering the patterns of altered PSG variables, no ...
Due to potential issues, several sleep laboratories conduct sleep bruxism diagnosis without the use of a camera, instead relying mostly on electromyographic monitoring. The purpose of the study was to...
To provide an updated comparison of apnea-hypopnea index (AHI), oxygen desaturation index (ODI), respiratory disturbance index (RDI), oxygen saturation (O...
Primary studies were identified through PubMed, Scopus, CINAHL, and Cochrane....
A systematic review was performed by searching databases from inception through August 2021. Only studies examining simultaneous monitoring of a PSSD and PSG were included. Respiratory indices AHI, OD...
A total of 24 studies (N = 1644 patients) were included. The mean age was 49.5 ± 12.0 (range = 13-92), mean body mass index (BMI) was 30.4 ± 5.7 (range = 17-87), and 69.4% were male. Meta-correlation ...
Respiratory indices correlate strongly between PSSD and PSG, which is further supported by meta-regressions results. PSSD might be a valuable cost and time-saving OSA screening tool....
It is estimated that half of Canadians have insufficient sleep, which over time is associated with poor physical and mental health. Currently, the only publicly funded option for the diagnosis of slee...
We performed a systematic literature search of the clinical evidence to identify diagnostic accuracy, test failures and subjective measures of patient preferences. We assessed the risk of bias of each...
We included 10 studies that reported on diagnostic accuracy and found level 2 polysomnography had sensitivity ranging between 0.76-1.0 and specificity ranging between 0.40-1.0 (GRADE: Moderate to Very...
Level 2 polysomnography may have good test performance for adults and children, with adequate diagnostic accuracy, compared with level 1 polysomnography. The economic analyses showed that level 2 poly...